vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $19.2M, roughly 1.4× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -18.0%, a 11.2% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 36.8%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
APYX vs MSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $27.6M |
| Net Profit | $-1.3M | $-5.0M |
| Gross Margin | 62.6% | 23.4% |
| Operating Margin | 0.1% | -4.9% |
| Net Margin | -6.8% | -18.0% |
| Revenue YoY | 34.7% | -10.9% |
| Net Profit YoY | 71.9% | -1840.5% |
| EPS (diluted) | — | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $27.6M | ||
| Q3 25 | $12.9M | $27.2M | ||
| Q2 25 | $11.4M | $34.4M | ||
| Q1 25 | $9.4M | $32.3M | ||
| Q4 24 | $14.2M | $29.4M | ||
| Q3 24 | $11.5M | $28.2M | ||
| Q2 24 | $12.1M | $16.9M | ||
| Q1 24 | $10.2M | $13.6M |
| Q4 25 | $-1.3M | $-5.0M | ||
| Q3 25 | $-2.0M | $-1.5M | ||
| Q2 25 | $-3.8M | $-287.4K | ||
| Q1 25 | $-4.2M | $1.0M | ||
| Q4 24 | $-4.6M | $-256.0K | ||
| Q3 24 | $-4.7M | $700.9K | ||
| Q2 24 | $-6.6M | $-2.8M | ||
| Q1 24 | $-7.6M | $-549.0K |
| Q4 25 | 62.6% | 23.4% | ||
| Q3 25 | 64.4% | 24.1% | ||
| Q2 25 | 62.3% | 9.5% | ||
| Q1 25 | 60.1% | 21.8% | ||
| Q4 24 | 63.0% | 26.9% | ||
| Q3 24 | 60.5% | 28.9% | ||
| Q2 24 | 61.7% | 13.0% | ||
| Q1 24 | 58.1% | 23.4% |
| Q4 25 | 0.1% | -4.9% | ||
| Q3 25 | -6.5% | 0.7% | ||
| Q2 25 | -22.6% | -15.9% | ||
| Q1 25 | -32.4% | 3.7% | ||
| Q4 24 | -21.4% | 3.2% | ||
| Q3 24 | -31.6% | 7.3% | ||
| Q2 24 | -45.7% | -14.4% | ||
| Q1 24 | -64.6% | -2.3% |
| Q4 25 | -6.8% | -18.0% | ||
| Q3 25 | -15.4% | -5.7% | ||
| Q2 25 | -33.2% | -0.8% | ||
| Q1 25 | -44.0% | 3.1% | ||
| Q4 24 | -32.5% | -0.9% | ||
| Q3 24 | -40.9% | 2.5% | ||
| Q2 24 | -54.0% | -16.4% | ||
| Q1 24 | -74.0% | -4.0% |
| Q4 25 | — | $-0.23 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | $-0.19 | $-0.16 | ||
| Q1 24 | $-0.22 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | $2.6M |
| Stockholders' EquityBook value | $14.5M | $11.6M |
| Total Assets | $66.8M | $75.4M |
| Debt / EquityLower = less leverage | 2.58× | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | $1.1M | ||
| Q2 25 | $29.3M | $775.4K | ||
| Q1 25 | $31.0M | $445.4K | ||
| Q4 24 | $31.7M | $355.7K | ||
| Q3 24 | $28.0M | $588.9K | ||
| Q2 24 | $32.7M | $2.1M | ||
| Q1 24 | $37.3M | $9.4M |
| Q4 25 | $37.5M | $2.6M | ||
| Q3 25 | $37.5M | $2.6M | ||
| Q2 25 | $37.5M | $2.6M | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $14.5M | $11.6M | ||
| Q3 25 | $5.8M | $10.1M | ||
| Q2 25 | $7.3M | $11.7M | ||
| Q1 25 | $10.5M | $12.0M | ||
| Q4 24 | $14.2M | $10.9M | ||
| Q3 24 | $11.0M | $11.2M | ||
| Q2 24 | $14.7M | $10.5M | ||
| Q1 24 | $20.3M | $13.3M |
| Q4 25 | $66.8M | $75.4M | ||
| Q3 25 | $57.4M | $73.3M | ||
| Q2 25 | $58.2M | $77.4M | ||
| Q1 25 | $60.2M | $82.7M | ||
| Q4 24 | $64.8M | $82.7M | ||
| Q3 24 | $60.7M | $82.1M | ||
| Q2 24 | $65.4M | $82.4M | ||
| Q1 24 | $70.7M | $44.2M |
| Q4 25 | 2.58× | 0.22× | ||
| Q3 25 | 6.41× | 0.26× | ||
| Q2 25 | 5.17× | 0.22× | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-1.7M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-1.7M | ||
| Q3 25 | $-3.5M | $1.1M | ||
| Q2 25 | $-1.2M | $-1.6M | ||
| Q1 25 | $-702.0K | $1.7M | ||
| Q4 24 | $-2.9M | $1.1M | ||
| Q3 24 | $-4.4M | $3.6M | ||
| Q2 24 | $-4.3M | $-2.6M | ||
| Q1 24 | $-6.3M | $-1.4M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
